1. Home
  2. UBXG vs ATNM Comparison

UBXG vs ATNM Comparison

Compare UBXG & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UBXG
  • ATNM
  • Stock Information
  • Founded
  • UBXG 2018
  • ATNM 2000
  • Country
  • UBXG China
  • ATNM United States
  • Employees
  • UBXG N/A
  • ATNM N/A
  • Industry
  • UBXG
  • ATNM Biotechnology: Pharmaceutical Preparations
  • Sector
  • UBXG
  • ATNM Health Care
  • Exchange
  • UBXG Nasdaq
  • ATNM Nasdaq
  • Market Cap
  • UBXG 60.1M
  • ATNM 50.2M
  • IPO Year
  • UBXG 2024
  • ATNM N/A
  • Fundamental
  • Price
  • UBXG $2.00
  • ATNM $1.65
  • Analyst Decision
  • UBXG
  • ATNM Strong Buy
  • Analyst Count
  • UBXG 0
  • ATNM 2
  • Target Price
  • UBXG N/A
  • ATNM $4.50
  • AVG Volume (30 Days)
  • UBXG 597.6K
  • ATNM 122.2K
  • Earning Date
  • UBXG 01-01-0001
  • ATNM 11-13-2025
  • Dividend Yield
  • UBXG N/A
  • ATNM N/A
  • EPS Growth
  • UBXG N/A
  • ATNM N/A
  • EPS
  • UBXG N/A
  • ATNM N/A
  • Revenue
  • UBXG $39,603,353.00
  • ATNM N/A
  • Revenue This Year
  • UBXG N/A
  • ATNM N/A
  • Revenue Next Year
  • UBXG N/A
  • ATNM N/A
  • P/E Ratio
  • UBXG N/A
  • ATNM N/A
  • Revenue Growth
  • UBXG N/A
  • ATNM N/A
  • 52 Week Low
  • UBXG $1.84
  • ATNM $1.03
  • 52 Week High
  • UBXG $13.60
  • ATNM $2.41
  • Technical
  • Relative Strength Index (RSI)
  • UBXG 33.04
  • ATNM 48.71
  • Support Level
  • UBXG $1.84
  • ATNM $1.61
  • Resistance Level
  • UBXG $2.96
  • ATNM $1.70
  • Average True Range (ATR)
  • UBXG 0.30
  • ATNM 0.07
  • MACD
  • UBXG -0.09
  • ATNM -0.01
  • Stochastic Oscillator
  • UBXG 12.69
  • ATNM 42.86

About UBXG U-BX Technology Ltd. Ordinary Shares

U-BX Technology Ltd is focused on providing value-added services using artificial intelligence-driven technology to businesses within the insurance industry, including insurance carriers and brokers. It helps institutional clients obtain visibility on various social media platforms and generate revenue based on consumers' clicks, views, or its clients' promotion time through those channels. The company derives a majority of its revenue by providing digital promotion services to its clients and also engages in providing risk assessment services, and value-added bundled benefits. It has developed an algorithm named Magic Mirror, to calculate payout risks for insurance carriers to underwrite auto insurance coverage. Geographically, all of the company's revenue is derived from Mainland China.

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

Share on Social Networks: